Koronis Pharmaceuticals Inc., a Seattle-based developer of antiviral therapeutics, has raised $20 million in Series D funding. Pacific Horizon Ventures led the deal, and was joined by fellow return backer Asset Management Company.
Return to search
![]()
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.